Microbial challenge test of a novel epoprostenol sodium formulation
Dirk Bandilla,1 Marcel Goverde,2 Paolo Giudici,1 Olivier Lambert1 1Actelion Pharmaceuticals Ltd., Allschwil, 2MGP Consulting GmbH, Binningen, Switzerland Aim: The aim of the current study was to present a comprehensive display of antimicrobial activity of a novel epoprostenol sodium formulation with...
Saved in:
Main Authors: | Bandilla D (Author), Goverde M (Author), Giudici P (Author), Lambert O (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension
by: Lambert O, et al.
Published: (2012) -
Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted
by: Lambert O, et al.
Published: (2012) -
Droplet Size and Distribution of Nebulized 3% Sodium Chloride, Albuterol, and Epoprostenol by Phase Doppler Particle Analyzer
by: Kelly McDermott, BS, RRT-ACCS, et al.
Published: (2021) -
Epoprostenol for very low birth weight (VLBW) infants: a novel dilution protocol
by: S. Rugolotto, et al.
Published: (2013) -
Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy
by: Julia Timofeev, et al.
Published: (2013)